TherapeuticsMD, Inc. (TXMD) Operating cash flow 2016–2025
TherapeuticsMD, Inc. (TXMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$2.5MFY2025 · since FY2016: -$69.1M → $2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5M | +109.7% |
| FY2024 | $1.2M | +105.1% |
| FY2023 | -$23.1M | -346.6% |
| FY2022 | $9.4M | +106.6% |
| FY2021 | -$142.7M | +10.5% |
| FY2020 | -$159.5M | +3.8% |
| FY2019 | -$165.7M | -55.1% |
| FY2018 | -$106.8M | -40.3% |
| FY2017 | -$76.2M | -10.1% |
| FY2016 | -$69.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice